Concepedia

Masanao Sanagi

MS

Statistics

Publications

8

Citations

140

H-Index

8

Active since

2001

Affiliations

Astellas Pharma (Japan)(Current)

Masanao Sanagi is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and endothelin receptor antagonists.

Publications per year

2001–2019

8

Publications

8

Distinct Properties of Telmisartan on Agonistic Activities for Peroxisome Proliferator-Activated Receptor γ among Clinically Used Angiotensin II Receptor Blockers: Drug-Target Interaction Analyses

Hirotoshi Kakuta, Eiji Kurosaki, Tatsuya Niimi et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 26 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Effect of L-DOPA/Benserazide on Propagation of Pathological α-Synuclein

Aki Shimozawa, Yuuki Fujita, Hiromi Kondo et al. · Frontiers in Neuroscience · 2019 · 22 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats

Hironori Yuyama, Akira Fujimori, Masanao Sanagi et al. · European Journal of Pharmacology · 2004 · 20 citations

Medicine, Pharmacology, Physiology +10

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist

Hironori Yuyama, Masanao Sanagi, Akiko Koakutsu et al. · European Journal of Pharmacology · 2003 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Antifibrotic Effects of Pirfenidone in Rat Proximal Tubular Epithelial Cells

Koji Takakura, Atsuo Tahara, Masanao Sanagi et al. · Renal Failure · 2012 · 17 citations

Medicine, Nephrology, Pharmacology +17

1–5 of 8